Effect of living donor liver transplantation on outcome of children with inherited liver disease and hepatocellular carcinoma

Clinical Transplantation

Volumn 20, Issue 6, 2006, Pages 776-782

  Özçay, Figen ^a   Canan, Oǧuz ^a   Bilezikçi, Banu ^a   Torgay, Adnan ^a   Karakayali, Hamdi ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Progressive familial intrahepatic cholestasis; Tyrosinemia; Wilson's disease

Indexed keywords

CISPLATIN; DOXORUBICIN; PREDNISOLONE; TSUKUBAENOLIDE;

ADOLESCENT; ALAGILLE SYNDROME; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SCREENING; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FAMILIAL DISEASE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NODULE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR RECURRENCE; TYROSINEMIA; WILSON DISEASE;

ADOLESCENT; BIOPSY; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CHOLESTASIS, INTRAHEPATIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATOLENTICULAR DEGENERATION; HUMANS; INCIDENCE; INFANT; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TYROSINEMIAS;

EID: 33750844321     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00571.x     Document Type: Article

References (27)

1. Bellani FF, Massimino M. Liver tumors in childhood: Epidemiology and clinics. J Surg Oncol Suppl 1993: 3: 119.
2. Moore SW, Millar AJ, Hadley GP, Schneider JW. Hepatocellular carcinoma in children. Pediatr Surg Int 1997: 12: 266.
3. Czauderna P, Mackinlay G, Perilongo G et al. Hepatocellular carcinoma in children: Results of the first prospective study of the International Society of Pediatric Oncology Group. J Clin Oncol 2002: 20: 2798.
4. Czauderna P. Adult type vs. childhood hepatocellular carcinoma - are they the same or different lesions? Biology, natural history, prognosis, and treatment. Med Pediatr Oncol 2002: 39: 519.
5. Chen JC, Chen CC, Chen WJ, Lai HS, Hung WT, Lee PH. Hepatocellular carcinoma in children. Clinical review and comparison with adult cases. J Pediatr Surg 1998: 33: 1350.
6. Prieto-Alamo MJ, Laval F. Deficient DNA-ligase activity in the metabolic disease tyrosinemia type 1. Proc Natl Acad Sci USA 1998: 95: 12614.
7. Weinberg AG, Mize CE, Worthen HG. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr 1976: 88: 434.
8. Al -D halimy M, Overturf K, Finegold M, Grompe M. Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. Mol Genet Metab 2002: 75: 38.
9. van Spronsen FJ, Bijleveld CM, van Maldegem BT, W ijburg FA. Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro-methylbenzoyl)-1, 3-cyclohexanedione treatment. J Pediatr Gastroenterol Nutr 2005: 40: 90.
10. Wilkinson ML, Portmann B, WilliamsR. Wilson's disease and hepatocellular carcinoma: Possible protective role of copper. Gut 1983: 24: 767.
11. Alonso EM, Snover DC, Montag A, Freese DK, W hitington PF. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994: 18: 128.
12. Scheers I, Bachy V, Stehenne X, Sokal EM. Risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders. J Pediatr 2005: 146: 414.
13. American Joint Committee on Cancer. Cancer Staging Handbook, 6th edn. New York, NY: Hamilton Press, 2003, 145.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48.900 necropsies. Cancer 1954: 7: 462.
15. Reyes JD, Carr B, Dvorchik I et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood in adolescence. J Pediatr 2000: 136: 795.
16. Kneteman NM, Oberholzer J, Al Saghier M et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 2004: 10: 1301.
17. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 334: 693.
18. Sarasin FP, Giostra E, Mentha G, Hadengue A. Partial hepatectomy or orthotopic liver transplantation for the treatment of respectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998: 28: 436.
19. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001: 33; 1394.
20. Superina R, Bilik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996: 31: 835.
21. van Spronsen FJ, Smit GP, Wijburg FA, Thomasse Y, Visser G, Heymans HS. Tyrosinaemia type I: Considerations of treatment strategy and experiences with risk assessment, diet and transplantation. J Inherit Metab Dis 1995: 18: 111.
22. L indstedt S, H olme E, L ock EA, H jalmarson O, S trandvik B. Treatment of hereditary tyrosinemia type I by inhibition of 4-hydroxyphenylpyruvatedioxygenase. Lancet 1992: 340: 813.
23. Ujhazy P, Ortiz D, Misra S et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 2001: 34: 768.
24. Kamamoto Y, Makiura S, Sugihara S, Hiasa Y, Arai M. The inhibitory effect of copper on DL-ethionine carcinogenesis in rats. Cancer Res 1973: 33: 1129.
25. Cheng WS, Govindarajan S, Redeker AG. Hepatocellular carcinoma in a case of Wilson's disease. Liver 1992: 12: 42.
26. Masaki T, Shiratori Y, Rengifo W et al. Hepatocellular carcinoma cell cycle: Study of Long-Evans cinnamon rats. Hepatology 2000: 32: 711.
27. Gembarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, M in AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000: 95: 1535.